structure ddbi-crbn e3 ubiquitin ligase complex thalidomide
1950s drug thalidomide administered sedative pregnant women led birth thousands children multiple defects despite teratogenicity thalidomide derivatives lenalidomide pomalidomide immunomodulatory drugs imids recently emerged effective treatments multiple myeloma 5q-deletion-associated dysplasia imids target e3 ubiquitin ligase cul4-rbx1-ddb1-crbn known crl4crbn promote ubiquitination ikaros family transcription factors ikzf1 ikzf3 crl4crbn present crystal structures ddb1-crbn complex bound thalidomide lenalidomide pomalidomide structure establishes crbn substrate receptor within crl4crbn enantioselectively binds imids using unbiased screen identified homeobox transcription factor meis2 endogenous substrate crl4crbn studies suggest imids block endogenous substrates meis2 binding crl4crbn ligase complex recruiting ikzf1 ikzf3 degradation dual activity implies small molecules can modulate e3 ubiquitin ligase thereby upregulate downregulate ubiquitination proteins
